我科自1998年4月～2000年6月,应用尿激酶治疗28例急性脑梗死患者,并与对照组相比较,观察尿激酶治疗急性脑梗死的疗效。 对 象 与 方 法 一、病例选择及排除标准 (1)颈内动脉系统脑血栓形成。(2)发病≤72h。(3)年龄18～75岁。(4)无昏迷者。(5)头颅CT或MR检查确诊为脑梗死,且证实无颅内出血者。(6)无出血性疾病史及出血倾向。(7)近期未曾施行过手术,无外伤及消化道溃疡病史。(8)近1周内未使用过 Our department from April 1998 ~ June 2000, the application of urokinase in 28 patients with acute cerebral infarction, and compared with the control group, to observe the efficacy of urokinase in the treatment of acute cerebral infarction. Subjects and methods A case selection and exclusion criteria (1) cerebral thrombosis of the internal carotid artery system. (2) the incidence of ≤ 72h. (3) Age 18 ~ 75 years old. (4) no coma. (5) head CT or MR diagnosis of cerebral infarction, and confirmed no intracranial hemorrhage. (6) No history of hemorrhagic disease and bleeding tendency. (7) The recent operation has not been performed, no history of trauma and peptic ulcer. (8) Not used in nearly 1 week